IDEAYA Biosciences
Latest round
- Series B
Last raised
- Jan 2018
Total raised
- $140M
Investors
- 14
About IDEAYA Biosciences
IDEAYA Biosciences, Inc. specializes in precision medicine for oncology, aiming to create therapeutics that target genetic vulnerabilities in tumors. Founded in 2015 in South San Francisco, US, the company has undergone strategic pivots in its research focus.IDEAYA Biosciences concentrates on precision medicine oncology therapeutics, primarily utilizing synthetic lethality. Their product pipeline includes drug candidates such as Darovasertib (IDE196), MAT2A (IDE397), and PARG (IDE161), which aim to exploit genetic vulnerabilities in tumors.58 mn. The company aims to explore new product launches in the coming years, targeting specific genetic alterations in cancer treatment. Additionally, it may expand into new markets, although specific regions have not been detailed. The exit of Novartis Institute for Biomedical Research from its stake suggests a strategic shift that may influence future partnerships and market positioning.
Who invested in IDEAYA Biosciences
14 investors across 2 rounds
See all investors in IDEAYA Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IDEAYA Biosciences
Who invested in IDEAYA Biosciences?
IDEAYA Biosciences has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IDEAYA Biosciences raised?
IDEAYA Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did IDEAYA Biosciences last raise money?
IDEAYA Biosciences's most recent round on record is a Series B, in Jan 2018.
What does IDEAYA Biosciences do?
IDEAYA Biosciences is a pharmaceuticals company.
Where is IDEAYA Biosciences headquartered?
IDEAYA Biosciences is headquartered in South San Francisco, US.
Which VCs invest in companies like IDEAYA Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at IDEAYA Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like IDEAYA Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.